Top Long Read Sequencing Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Long Read Sequencing Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Long Read Sequencing industry players.

Long Read Sequencing Market Competitive Landscape

The primary operational players have used a number of measures to increase their market presence because this is a market that is expanding quickly. As an example, Illumina will introduce its powerful Illumina Complete Long Read Prep, Human assay for human whole-genome sequencing in March 2023.

Top Players in Long Read Sequencing Market

  • Pacific Biosciences of California, Inc. (PacBio) (United States) 
  • Oxford Nanopore Technologies plc (United Kingdom) 
  • Illumina, Inc. (United States) 
  • BGI Genomics Co., Ltd. (China) 
  • 10x Genomics, Inc. (United States) 
  • Agilent Technologies, Inc. (United States) 
  • Thermo Fisher Scientific Inc. (United States) 
  • QIAGEN N.V. (Germany) 
  • Takara Bio Inc. (Japan) 
  • Danaher Corporation (United States) 
  • Novogene Co., Ltd. (China) 
  • New England Biolabs, Inc. (United States) 
  • Element Biosciences, Inc. (United States) 
  • Revvity, Inc. (United States) 
  • Eurofins Scientific SE (Luxembourg) 
  • Bio-Rad Laboratories, Inc. (United States) 
  • PerkinElmer, Inc. (United States) 
  • Roche Holding AG (Switzerland) 
  • Merck KGaA (Germany) 
  • Bio-Techne Corporation (United States)

Long Read Sequencing Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Long Read Sequencing Market size was valued at USD 595.81 million in 2023 and is poised to grow from USD 779.92 million in 2024 to USD 6723.02 million by 2032, growing at a CAGR of 30.9% during the forecast period (2025-2032).

The primary operational players have used a number of measures to increase their market presence because this is a market that is expanding quickly. As an example, Illumina will introduce its powerful Illumina Complete Long Read Prep, Human assay for human whole-genome sequencing in March 2023. 'Pacific Biosciences of California, Inc. (PacBio) (United States) ', 'Oxford Nanopore Technologies plc (United Kingdom) ', 'Illumina, Inc. (United States) ', 'BGI Genomics Co., Ltd. (China) ', '10x Genomics, Inc. (United States) ', 'Agilent Technologies, Inc. (United States) ', 'Thermo Fisher Scientific Inc. (United States) ', 'QIAGEN N.V. (Germany) ', 'Takara Bio Inc. (Japan) ', 'Danaher Corporation (United States) ', 'Novogene Co., Ltd. (China) ', 'New England Biolabs, Inc. (United States) ', 'Element Biosciences, Inc. (United States) ', 'Revvity, Inc. (United States) ', 'Eurofins Scientific SE (Luxembourg) ', 'Bio-Rad Laboratories, Inc. (United States) ', 'PerkinElmer, Inc. (United States) ', 'Roche Holding AG (Switzerland) ', 'Merck KGaA (Germany) ', 'Bio-Techne Corporation (United States)'

Next-generation sequencing (NGS) technologies are widely adopted in research applications across various fields, including genomics, transcriptomics, and epigenomics. Long read sequencing provides additional insights into genome assembly, gene expression, and DNA modification patterns, driving its adoption in NGS-based research.

Increasing Adoption of Long Read Sequencing: Long read sequencing technologies are gaining significant traction in the market due to their ability to provide more comprehensive and accurate genomic information compared to short read sequencing. This trend is driven by the increasing demand for applications such as genome assembly, structural variant analysis, and transcriptomics.

North America held a 50.85% share of the global market in 2022 as a result of the existence of significant players like Pacific Biosciences, the accessibility of a strong informatics network, and established laws for the approval and marketing of goods and services for genetic testing. Furthermore, it is projected that the growing academic and clinical use of genomic methods in the US will speed up market expansion there.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Next Generation Sequencing Market
Buy Now GET FREE SAMPLE
DNA Sequencing Market
Buy Now GET FREE SAMPLE
Protein Sequencing Market
Buy Now GET FREE SAMPLE
Whole Exome Sequencing Market
Buy Now GET FREE SAMPLE
Next-Generation Sequencing Services Market
Buy Now GET FREE SAMPLE
Metagenomic Sequencing Market
Buy Now GET FREE SAMPLE
Clinical Oncology Next Generation Sequencing Market
Buy Now GET FREE SAMPLE
Digital Genome Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Long Read Sequencing Market
Long Read Sequencing Market

Report ID: SQMIG35H2219

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE